Skip to main content
OpenTrials
Completed

NCT Number: NCT05015322

Comparison of the Effectiveness of the Ultrasound Guided Injections in Patients With Shoulder Impingement Syndrome

Shoulder pain, which is the third most common cause of musculoskeletal pain, has different etiologies. Muscle, bone structures and connective tissue pathologies can cause shoulder pain. Impingement syndrome (IS), which can cover many terms such as rotator cuff disorders, tendinitis and tears, is one of the most common pathologies of shoulder pain.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Shoulder Impingement Joint Diseases Musculoskeletal Diseases Shoulder Impingement Syndrome Shoulder Injuries Ultrasound Guided Injection Wounds and Injuries

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

About this study

The hypothesis of this study was that injection types including ACJ would increase treatment efficacy.Therefore, this study investigated the six-month follow-up results of patients undergoing SA injection and SSNB and those receiving SA and ACJ injection.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients aged 18-65,
  • who were suffering from shoulder pain for more than three months and
  • who were diagnosed with IS.
  • All patients included in the study were diagnosed with IS using Shoulder Magnetic Resonance imaging.

Exclusion criteria

  • the presence of cervical radiculopathy;
  • undergoing shoulder operation before;
  • the presence of central nervous system or
  • the presence of rheumatological disease, and polyneuropathy;
  • receiving physical therapy in the shoulder area with a diagnosis of IS within the last six months; and
  • receiving any injection therapy in the past.

Treatment and study plan

bupivacaine and methylprednisolone

Drug

5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area

Primary outcomes

  1. Visual Analogue Scale (VAS)

    Time frame: six month

    for pain. 0: no pain at all, 10: worst pain imaginable

Secondary outcomes

  1. Shoulder pain and disability index (SPADI)

    Time frame: six month

    This scale was developed to measure pain and disability associated with shoulder pain. It consists of two parts evaluating pain and disability.

  2. Short-Form 12 (SF-12)

    Time frame: six month

    The SF-12 has a physical (SF12-PCS) and mental (SF12-MCS) state assessment scale

Sponsors and collaborators

Lead sponsor

Bursa Yuksek Ihtisas Training and Research Hospital

Other Gov

Registry information

Official study title

Comparison of the Effectiveness of the Ultrasound Guided Subacromial, Acromioclavicular With Subacromial Injection and Suprascapular Nerve Block in Patients With Shoulder Impingement Syndrome ; A Randomized Controlled, Single Blind, Clinical Trial

Important dates

Study start
2017
Primary completion
2021
Study completion
2021
First posted
Aug 20, 2021
Registry last updated
Aug 20, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.